Study to Evaluate ARD-101 in Adults Receiving Bariatric Surgery
Status:
Not yet recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety and efficacy of twice-daily ARD-101 in
subjects with relevant weight regain at least one year after bariatric surgery (sleeve
gastrectomy or gastric bypass).